Nonviral jet injection is an applicable technology for in vivo gene transfer of naked DNA. However, little is known about the biodistribution and clearance of jet-injected DNA, or about its localization within tissue and cells. Therefore, in this study we analyzed the intratumoral and systemic biodistribution of jet-injected naked DNA in human colon carcinoma-bearing NCr-nu/nu mice, which were jet-injected with the pCMV␤ plasmid DNA. Intratumoral and systemic plasmid DNA biodistribution was analyzed 5, 10, 20, and 40 min and 3, 6, 24, 48, and 72 hr after jet injection, using quantitative real-time polymerase chain reaction. In the tumors, a rapid drop in naked DNA load within 24 hr of jet injection was shown. Detailed analysis of intratumoral distribution of rhodamine-labeled DNA revealed the presence of plasmid DNA within tumor cells 5 min after jet injection and further accumulation of significant DNA amounts in the cell nuclei 30 to 60 min after jet injection. In the blood, DNA amounts rapidly dropped within 10 to 40 min of jet injection to less than 0.001 pg of plasmid per 250 ng of tissue DNA and only minimal plasmid DNA dissemination was detected in liver, lung, spleen, kidney, and ovaries, which was cleared 3 to 6 hr after jet injection. By contrast, in heart, bone marrow, and brain almost no plasmid DNA was detectable.
INTRODUCTION I
N GENE THERAPY, including cancer gene therapy, the majority of delivery systems employed are of retroviral or adenoviral origin . Because viral vectors have different disadvantages, such as provocation of unwanted immune responses, virus-associated toxicities, viral recombination, or insertional mutagenesis, many investigators have shifted their attention toward nonviral transfer systems, especially if timely restricted expression of the transgene is attempted (Niidome and Huang, 2002) . The use of naked DNA is particularly attractive, because of its low immunogenicity, minimal or absent toxicity and its simplicity of use. Besides the simple needle and syringe injection, most applications of naked DNA are associated with the employment of physical transfer technologies for the introduction of naked DNA into the targeted tissue. Such physical technologies include in vivo electroporation, focused ultrasound, particle bombardment (biolistic transfer), or jet injection (Li and Huang, 2000; Somiari et al., 2000; Niidome and Huang, 2002) . Some of these tech-nologies have entered the level of clinical testing in gene therapy protocols.
We and others have demonstrated that efficient gene transfer of naked DNA into tumors can be achieved in vivo, if jet injection technology is used (Walther et al., 2001) . Jet injection-mediated intratumoral gene transfer of reporter gene-expressing plasmids or therapeutic gene-expressing constructs led to the expression of these genes in various tumor models, using only small amounts of naked DNA (Walther et al., 2001 (Walther et al., , 2002 . Similar results have been reported when muscle tissue was targeted for jet injection gene transfer (Furth et al., 1992 (Furth et al., , 1995 Cartier et al., 2000) .
Apart from the fact that jet injection gene transfer is effective for introducing naked DNA into tumors in vivo, there is a need to analyze and understand the fate of naked DNA applied to tumors. There are various reports dealing with the biodistribution of transduced naked DNA after needle injection, in vivo electrotransfer, or biolistic transfer (Dupuis et al., 2000; Pilling et al., 2002; Cappelletti et al., 2003) . However, nothing is known about the fate of naked DNA in vivo if applied by jet injection. We therefore analyzed the time-dependent biodistribution of jet-injected plasmid DNA in tumors and the systemic dissemination of naked DNA, using quantitative real-time polymerase chain reaction (PCR). This type of real-time PCR is a sensitive method allowing quantitative detection of small amounts of plasmid DNA jet-injected into tumors or of plasmid disseminated to the blood circulation or to other organs. Several reports have demonstrated the usefulness of this method for biodistribution studies of naked DNA gene transfer (Hackett et al., 2000; Maruyama et al., 2002; Rose et al., 2002) . In addition, we employed quantitative real-time reverse transcription (RT)-PCR to analyze reporter gene mRNA expression in jet-injected tumors and to evaluate the potential transcriptional activity of disseminated plasmid in other organs.
We further analyzed the path taken by plasmid DNA within the cells of jet-injected tumors to localize cellular distribution in more detail by confocal fluorescence microscopy. Using this approach, we were able to provide more insight into the localization of jet-injected naked DNA at the tissue and cellular levels during the time course of intratumoral DNA clearance.
MATERIAL AND METHODS

Preparation of plasmid DNA
The pCMV␤ plasmid (Clontech, Palo Alto, CA) was used for expression of the bacterial ␤-galactosidase gene (lacZ). The plasmid was amplified in One Shot competent Escherichia coli bacteria (Invitrogen, Groningen, The Netherlands), purified with a JETSTAR purification kit (GENOMED, Löhne, Germany), and dissolved in phosphate buffer (150 mM Na 2 HPO 4 /NaH 2 PO 4 ; pH 7.0) to a final concentration of 1 g of DNA per microliter. This plasmid DNA was used for intratumoral in vivo jet injection.
To study the tissue and intracellular localization of plasmid DNA after jet injection, the rhodamine-labeled pGene-GRIP plasmid (Gene Therapy Systems, San Diego, CA) was used.
Intratumoral in vivo jet injection of naked pCMV␤ plasmid DNA
For the nonviral in vivo gene transfer, female NCr-nu/nu mice xenotransplanted with patient-derived human colon carcinoma Colon5737 cells were used . When tumors reached a size of approximately 6 ϫ 6 mm the tumor-bearing animals were anesthetized and received five intratumoral jet injections of pCMV␤ plasmid DNA through the skin, using a Swiss Injector prototype (Electro Medical Systems, Nyon, Switzerland) at a pressure of 3.0 bar, a condition optimized in previous studies for in vivo gene transfer (Walther et al., 2002) . These jet injections were applied at five different sites in the tumor (see Fig. 4B ). The respective control animals were jet-injected with saline. Each jet injection applied 10 l of plasmid solution containing naked plasmid DNA at 1 g/l. Therefore, each animal received a total dose of 50 g of pCMV␤ plasmid DNA. Five, 10, 20, and 40 min and 3, 6, 24, 48 , and 72 hr after jet injection, animals (n ϭ 3 per time point) were killed and tumors were removed and snap frozen in liquid nitrogen for further analysis. Furthermore, whole blood, liver, lung, heart, bone marrow, spleen, kidney, ovaries, and brain were removed and shock frozen in liquid nitrogen for further analysis.
For intratumoral and cellular localization of rhodamine-labeled plasmid DNA, animals received five jet injections of pGeneGRIP plasmid-containing solution. The animals were killed 5, 30, and 60 min (n ϭ 2 animals per time point) after jet injection, and tumors were removed and shock frozen for further analysis.
Quantitative real-time PCR analysis of pCMV␤ plasmid DNA distribution in jet-injected animals
For detection of pCMV␤ plasmid DNA, cellular DNA was isolated from serial cryosections (20 m) of tumors and the respective organs, using a QIAamp DNA mini kit (Qiagen, Valencia, CA).
Each quantitative real-time PCR (95°C for 30 sec; 45 cycles of 95°C for 10 sec, 62°C for 10 sec, and 72°C for 10 sec) was performed with 250 ng of cellular DNA in a LightCycler reaction (LightCycler DNA master hybridization probes kit; Roche Diagnostics, Mannheim, Germany) in duplicate per sample. For the pCMV␤ plasmid a 127-bp amplicon (forward primer, 5Ј-AAGCAAAAAAGAAGTCACCATG-3Ј; fluorescein isothiocyanate [FITC]-labeled probe, 5Ј-CGGTCTGGGAGGCATT-GGT-3Ј-FITC; LCRed640-labeled probe, LCRed640-5Ј-GG-ACACCAGCAAGGAGCTGCT-3Ј; reverse primer, 5Ј-GTAA-AACGACGGGATCGC-3Ј) was produced, which was detected by the gene-specific fluorescein-and LCRed640-labeled hybridization probes (syntheses of primers for pCMV␤: BioTeZ, Berlin, Germany; syntheses of probes for lacZ: TIB MOLBIOL, Berlin, Germany) (Fig. 1A) .
pCMV␤ concentrations in 250 ng of cellular DNA were calculated by comparison with a "spiked" standard curve of pCMV␤ plasmid. For spiking, pCMV␤ plasmid DNA was serially diluted (0.005, 0.05, 0.5, 5, 10, 30, 50 , and 80 ng in duplicate) in 250 ng of cellular DNA isolated from the human colon carcinoma cell line SW480 or from the organs of test animals.
Each organ-based spiked standard curve was generated in parallel in each real-time PCR run ( Fig. 2A-C) to ensure the accuracy of DNA quantitation. The quality of PCR products was evaluated for each run by the corresponding melting curves as shown in Fig. 2E .
Quantitative real-time RT-PCR analysis of LacZ expression in jet-injected tumors
Total RNA from cryosections of tumors or organs was isolated by the TRIzol method according to the manufacturer's instructions (Life Technologies, Karlsruhe, Germany). To prevent potential contamination with plasmid DNA, all RNA probes were treated with RNase-free DNase I (Roche Diagnostics). The reverse transcriptase (RT) reaction was performed with 30 ng of total RNA isolated from tumor tissues or respective organs (murine leukemia virus [MuLV] reverse transcriptase; PerkinElmer, Weiterstadt, Germany).
Quantitative real-time PCR (95°C for 30 sec; 45 cycles of 95°C for 10 sec, 62°C for 10 sec, and 72°C for 10 sec) was done with the LightCycler (LightCycler DNA master hybridization probes kit; Roche Diagnostics). Expression of the lacZ gene was determined in duplicate for each sample. For lacZ a 101-bp amplicon (forward primer, 5Ј-CCGTTGATGTTGAAGTGG-3Ј; FITC-labeled probe, 5Ј-GCGCGGATTGGCCTGAACT-3Ј-FITC; LCRed640-labeled probe, LCRed640-5Ј-CAGCTG-GCGCAGGTAGCAGA-3Ј; reverse primer, 5Ј-CTAATCC-GAGCCAGTTTACCC-3Ј) was produced,which was detected by gene-specific fluorescein-and LCRed640-labeled hybridization probes (syntheses of primers for lacZ: BioTeZ; syntheses of probes for lacZ: TIB MOLBIOL) (Fig. 1B) .
Calibrator cDNA derived from a stably pCMV␤-transduced LacZ-expressing cell clone (human colon carcinoma cell line SW480) was employed in serial dilutions (3, 10, 30, 100, 300, and 500 ng in duplicate) simultaneously in each run and served as internal standard for LacZ calculations. LacZ expression (mean of the duplicates) for each tumor sample was calculated and expressed as relative fold LacZ mRNA expression in relation to the calibrator cell line. For all RT-PCR runs the quality of corresponding PCR products was evaluated on the basis of melting curves.
Isolation of nuclear DNA from jet-injected tumor tissues
For the isolation of nuclei from jet-injected tumor tissues, tumors were cryosectioned (20 m) and 10 to 20 sections were collected in an Eppendorf tube. The sections were homogenized in 1 ml of lysis buffer (40 mM sodium citrate, 1% Triton X-100) on ice. After a 5-min incubation on ice the supernatant was transferred to another tube and centrifuged at 1000 rpm for 5 min. The nuclear pellet was washed three times to remove potential cytoplasmic contaminations (see Fig. 6C ). To the nuclear pellet (quality of nuclear preparations was evaluated by light microscopy; see Fig. 6C ) 1 ml of TRIzol (Invitrogen) was added and the mixture was incubated for 5 min at room temperature. Thereafter, 0.2 ml of chloroform was added and the mixture was vortexed, incubated for 3 min at room temperature, and centrifuged at 14,000 rpm at 4°C. After transfer of the supernatant to another tube, 0.5 ml of isopropanol was added and the mixture was incubated for 10 min and centrifuged at 14,000 rpm for 10 min at 4°C. The DNA pellet was washed with 70% ethanol and then resuspended in 20 l of TE buffer (pH 7.0). This nuclear DNA was treated with DNase-free RNase and subjected to quantitative real-time PCR analysis for the mid DNA by jet injection. We analyzed the DNA load at defined time points after jet injection to evaluate the amount of DNA present within each tumor and to analyze the time course of DNA clearance after jet injection. To accomplish this, we used real-time PCR to quantitate the amount of DNA (see Fig.  2D and E), which was normalized to a standard curve generated by real-time PCR (see Fig. 2A -C) using serial dilutions of spiked pCMV␤ plasmid DNA as described. Figure 3 depicts the mean (n ϭ 3) total plasmid DNA load in tumors 5, 10, 20, and 40 min and 3, 6, 24, 48, and 72 hr after jet injection. As shown in Fig. 3 , the highest DNA amounts (about 12 g) were detected 5 min after intratumoral jet injection, representing 24% of the initial dose of 50 g of jet-injected naked plasmid DNA. In the relatively short period of 10 min after jet injection a rapid drop in DNA load in the tumors was observed. This phase of rapid DNA clearance was followed by a phase of slower elimination rate, which reached a minimum of 0.56-0.04 g of plasmid DNA load 24 to 72 hr after jet injection. This finding is a strong indication that within the first 5 min after jet injection more than 70% of the initial DNA is cleared from the tumor tissue, which might be attributed to "washout" by the blood flow in the well-vascularized tumors and also by processes of DNA degradation within the tumor.
To obtain more detailed insight concerning the biodistribution of plasmid DNA within tumors, a consecutive series of cryosections covering an entire tumor was analyzed for DNA load at each time point (Fig. 4A ). As shown in Fig. 4C and D, in representative tumors from three different animals 5 min and 24 hr after jet injection, a heterogeneous distribution of plasmid DNA was determined. This is reflected by the variations seen in DNA concentration in the various tumor fractions; this 
Confocal laser scanning microscopy
For confocal laser scanning microscopy, pGeneGRIP jet-injected tumors were removed 5, 30, and 60 min after jet injection, cryosectioned (13 m), and fixed in 3% formaldehyde for 10 min, dehydrated with acetone, and permeabilized with 0.1% Triton. After thorough washing in phosphate-buffered saline (PBS), nuclei were stained for 1 min with TO-PRO-3 (Invitrogen Molecular Probes, Eugene, OR), washed with PBS, and dehydrated with 96% ethanol. The sections were then covered with Faramount (Dako, Carpinteria, CA) and evaluated with an LSM 510 META laser scanning microscope (Carl Zeiss, Jena, Germany) and analyzed with LSM 5 Image Examiner software (Carl Zeiss). Rhodamine was excited with laser light at 488 nm and TO-PRO-3 was excited with laser light at 647 nm. The fluorescence signals were detected with a dichroic beamsplitter UV/488/563/633 and the emission filter BP565-615 (rhodamine) or LP 650 (TO-PRO-3). In z stacks the slice thickness was 0.4 m and overlapping slices were used for three-dimensional reconstructions with thresholds according to the labels in the images.
RESULTS
Intratumoral jet injection and clearance of plasmid DNA in tumor
To evaluate the biodistribution of jet-injected naked DNA in tumor tissue, animals received a total of 50 g of pCMV␤ plasmight be due to the physical characteristics of the tissue-penetrating jet (Fig. 4A) . However, for both representative time points, plasmid DNA was detected throughout the entire tumor tissue (represented by the six cryosection fractions), although at different concentration levels ( Fig. 4C and D) . In fact, similar patterns of plasmid distribution were also shown for all other time points, including 48 and 72 hr after jet injection (data not shown). 
BIODISTRIBUTION OF JET-INJECTED
Cellular localization of rhodamine-labeled plasmid DNA after intratumoral jet injection
To analyze at the tissue and cellular levels the fate of naked DNA jet-injected into tumor, we used rhodamine-labeled pGeneGRIP plasmid DNA for in vivo jet injection. Five, 30, and 60 min after jet injection tumors were analyzed for localization of the labeled DNA, using fluorescence microscopy and confocal laser scanning microscopy. Figure 5 depicts the pattern of plasmid distribution in jet-injected tumors. Plasmid DNA is localized mainly in the intercellular space; some can also be found within the tumor cells. The microphotographs in Fig. 5 demonstrate the inhomogeneous spread pattern of plasmid DNA, which was generated by the jet force in the tissue and that is in agreement with data obtained by real-time PCR analysis (see Fig. 4 ).
To obtain a more detailed picture of plasmid DNA localization at the cellular level, tumors were analyzed by confocal scanning laser microscopy. The microphotographs in Fig. 6A show that as soon as 5 min after jet injection plasmid DNA was detected within tumor cells. Thirty to 60 min after jet injection a further increase in intracellular and perinuclear accumulation of labeled DNA was seen. More interestingly, clear nuclear penetration of labeled plasmid DNA was detectable 30 and 60 min after jet injection (Fig. 6A ). To evaluate whether such nuclear localization had already initiated as early as 5 min after jet injection, three-dimensional (z stack) analysis of the confocal laser scanning images was performed. As shown in Fig. 6B , small proportions of rhodamine-labeled plasmid DNA were localized in the cell nuclei of tumor tissue 5 min after jet injection.
To quantitatively complement these findings by confocal laser scanning microscopy, DNA from cell nuclei was isolated from the same tumor tissues shown in Fig. 6A and quantitative real-time PCR was performed to detect plasmid DNA. The purity of nuclear preparations was evaluated by light microscopy and by control of the washing buffer of the nuclear pellet for the presence of plasmid contamination (Fig. 6C) . The results depicted in Fig. 6D support our previous observation that, indeed, 5 min after jet injection small amounts of plasmid DNA (0.06 pg of plasmid DNA per 250 ng of nuclear DNA) were detectable in the cell nuclei. Over time a rapid nuclear plasmid accumulation was observed, reflected by an 13-fold increase in DNA load from 0.21 pg of plasmid DNA per 250 ng of nuclear DNA 30 min after jet injection to 2.8 pg of plasmid DNA per 250 ng of nuclear DNA 60 min after jet injection. These data provide evidence that jet injection permits rapid intratumoral and, more importantly, intracellular penetration of naked plasmid DNA associated with almost simultaneous nuclear localization of small proportions of jet-injected DNA.
Systemic biodistribution of plasmid DNA after intratumoral jet injection
Besides the analysis of the distribution of plasmid DNA within tumors, it is of crucial importance to monitor the systemic biodistribution of applied naked DNA. To accomplish this, we analyzed by real-time PCR samples of blood, liver, lung, kidney, spleen, ovary, heart, brain, and bone marrow from all treated animals at all time points after jet injection. This quantitative analysis was performed to provide information about the time-dependent biodistribution in these particular organs and the clearance of the DNA. Figure 7 shows the results for systemic plasmid biodistribution after intratumoral jet injection. Although at much lower plasmid DNA concentrations in the various organs (Ͼ240-fold lower compared with tumors), systemic leakage of the intratumorally jet-injected DNA was seen. Five minutes after intratumoral jet injection the highest level of plasmid DNA was observed in the blood of the animals (Fig. 7A) . However, the plasmid concentration rapidly dropped from about 48 to less than 5 pg of plasmid DNA per 250 ng of blood DNA within 20 min of jet injection. This decline in plasmid DNA in the blood of the animals was paralleled by the increase in plasmid DNA in the various organs, particularly in liver, lung, and kidney and at a much lower level in ovaries, spleen, brain, bone marrow, and heart ( Fig. 7B and Table 1 ). On comparing the DNA load in the various organs, the highest plasmid DNA concentrations were found in liver (37 pg of plasmid DNA per 250 ng of liver DNA) and lung (31 pg of plasmid DNA per 250 ng of lung DNA) 20 min after jet injection; these concentrations rapidly dropped within 40 min of jet injection and were almost completely cleared after 6 hr ( Fig. 7A and Table 1 ). An almost similar DNA clearance was observed in the kidneys. Only in one of three animals was a delayed clearance observed 3 hr after jet injection ( Fig. 7A and Table 1 ), whereas at this time point in the kidneys of the other animals only low amounts of plasmid DNA (Ͻ0.3 pg of plasmid DNA per 250 ng of kidney DNA) were detectable. The lowest plasmid DNA concentrations were determined in the brain and heart of the animals (Fig. 7B) . Taken together, in all organs (except blood) the highest plasmid DNA concentrations were most frequently measured within 40 min of jet injection, whereas clearance of this DNA was completed as soon as 3 to 6 hr after intratumoral jet injection. This is supported by the summarized data in Table 1 , showing that 6 hr after intratumoral jet injection none of the animals tested positively for pCMV␤ DNA in the organs (except blood).
Analysis of intratumoral and systemic LacZ expression after jet injection of pCMV␤ plasmid DNA
To determine to what extent jet-injected pCMV␤ plasmid DNA is transcriptionally active in jet-injected tumors and might also exert LacZ expression in other sites via systemic distribution, we tested LacZ mRNA expression in tumors and in organs (blood, liver, lung, kidney, ovary, spleen, brain, bone marrow, and heart), using real-time RT-PCR. Table 2 shows that in jet-injected tumors LacZ mRNA expression is detectable 24 hr after jet injection, reflected by a 322-fold relative expression level compared with stably LacZ-expressing SW480 calibrator cells. This mRNA expression remains at a high level 48 hr after jet injection, followed by a decline in expression level after 72 hr. In addition, the other organs and blood were tested for LacZ expression at all time points (5, 10, 20, and 40 min and 3, 6, 24, 48 , and 72 hr) after jet injection; however, we could not detect LacZ mRNA at these sites, although the real-time PCR detected plasmid DNA in all these tissues. Even those organs with the highest pCMV␤ concentrations, such as liver, lung, and kidney, did not express LacZ-specific mRNA. In fact, this is a strong indication that systemic biodistribution of intratumorally jet-injected DNA is not associated with transcriptional activity in other sites than the targeted tumor. 
DISCUSSION
In this in vivo study we investigated the time course of clearance and biodistribution of naked plasmid DNA applied intratumorally by jet injection. Previous in vivo studies have demonstrated that this nonviral gene transfer technology is efficient for transfer of various vector constructs in different tissue types, leading to effective expression of the respective transgenes (Ren et al., 2002; Walther et al., 2004) . Because nothing is known about the in vivo fate of focally jet-injected naked DNA in tumors or about its systemic biodistribution and clearance, our study has focused on this issue, using quantitative real-time PCR. For this we applied 50 g of pCMV␤ DNA by jet injection, knowing that such dosing had been shown to be effective for transgene expression in tumor tissue in vivo (Walther et al., 2001 (Walther et al., , 2002 .
In this study we have shown that shortly after jet injection a high proportion (more than 70%) of naked DNA is lost in the tumors. The effect of such rapid losses in DNA has also been reported in other studies, where naked DNA was applied by needle injection into muscle, liver, or tumors (Parker et al., 1999; Dupuis et al., 2000; Herweijer et al., 2001; Cappelletti et al., 2003; Kawase et al., 2003) . Because jet injection applies only small volumes at high pressure, the potential effect of seepage of the jet-injected volume is negligible and does not contribute to quantitative losses of DNA. When correlating this ob-
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FIG. 7. Time-dependent biodistribution of pCMV␤ plasmid DNA in the blood and various organs of animals after intratumoral jet injection, represented by the highest value of DNA load in the respective organs for each animal group. The plasmid DNA was quantified by real-time PCR (LightCycler) in each organ, using a spiked plasmid DNA standard curve for each quantification analysis. Each time point is represented by the mean value obtained in duplicate in the respective samples. The amounts of plasmid DNA shown were determined in 250 ng of blood DNA (whole blood) or in the respective organ tissue DNA. (A) Biodistribution in blood, liver, lung, and kidney; (B) biodistribution in ovary, spleen, brain, bone marrow, and heart. The SD was much less than 10% for all values determined.
servation of rapid decrease in DNA concentration in tumors with our finding of a significant increase in plasmid DNA in the blood within 5 min of jet injection, we conclude, that a proportion of jet-injected DNA is dispersed by the blood flow, contributing to the observed intratumoral losses. Such blood-mediated dispersion shortly after DNA application has also been observed by others after intramuscular or intratumoral administration of plasmid DNA (Parker et al., 1999; Kawase et al., 2003) . Although solid tumors often possess elevated hydrostatic pressure that hinders DNA dispersion, high tumor vascularization with regions of hyperpermeable endothelium might augment dispersion of jet-injected DNA from the injection site to the intracellular space (Baban and Seymour, 1998; Pouton and Seymour, 2001 ). In addition, degradative processes, such as nuclease activities in the target tissue, will contribute to the quantitative loss of intact plasmid DNA (Cappelletti et al., 2003; Walther et al., 2005) . We have shown, in a previous study, that particularly in tumor tissues high nucleolytic activities can be detected, causing more than 70% DNA degradation within 5 to 10 min of jet injection (Walther et al., 2005) . Despite the observed tremendous loss of jet-injected DNA within tumors, previous studies and this study have demonstrated that the remaining small proportions of plasmid DNA (Ͻ0.07%, 72 hr after jet injection) lead to transgene expression. In addition, our detailed analysis of plasmid distribution within tumor tissues clearly showed that jet injection permits inhomogeneous plasmid distribution and does affect the entire tissue (Fig. 4C and D, and Fig. 5 ). This represents an important prerequisite for effective transgene expression within tumors.
To gain more detailed insight into the in vivo path of jet-injected plasmid DNA, particularly shortly after application, we performed confocal scanning microscopy analysis with rhodamine-labeled DNA. As we have observed in these analyses, the majority of labeled DNA was typically localized within the intercellular space shortly after jet injection, which is in agreement with observations made in another, similar study of naked DNA gene transfer (Dupuis et al., 2000) . More interestingly, we have seen the rapid entry of labeled DNA into the cytoplasm and to a lesser extent into cell nuclei as early as 5 min after in vivo jet injection, followed by a significant increase in nuclear accumulation within 30 to 60 min. Regarding this issue, different kinetics of cellular DNA uptake were determined by other investigators, varying from cytoplasmic uptake in only a few minutes after application of naked DNA to several hours (24 hr) in injected muscle or in hepatic tissue after tail vein injection (Budker et al., 2000; Dupuis et al., 2000) . Our observation of plasmid DNA localization in the cytoplasm and cell nuclei shortly after jet injection might be the result of the high energy by which jet injection forces DNA into tumor tissue. Such a mode of application could have similar effects as shown, for example, in the hydrodynamic procedure leading to transient close DNA:cell contact as a pressure-dependent effect, which in turn augments cellular DNA uptake (Zhang et al., 1997) . Summarizing these findings, jet injection seems to positively influence the process of partitioning of plasmid DNA between the intracellular and intercellular space associated with any nonviral application of DNA by promoting rapid cellular uptake and nuclear translocation (Bureau et al., 2004) . Regarding the systemic biodistribution of plasmid DNA, we detected pCMV␤ DNA in the blood shortly after intratumoral jet injection; clearance occurred rapidly. Interestingly, this clearance of DNA from the blood correlated with the increase in plasmid DNA concentration in those organs particularly known to be well-vascularized tissues (e.g., liver, lung, and spleen). Therefore, dispersion of plasmid DNA from the circulation might lead to the observed short and time-restricted appearance of plasmid DNA in the other organs, which is then rapidly cleared within 6 hr of jet injection. Interestingly, similar kinetics of biodistribution for nonvirally applied DNA have been described by several authors in various in vivo models (Parker et al., 1999; Kawase et al., 2003; Bureau et al., 2004) . Our observation of complete clearance from all organs within 6 hr of jet injection is important regarding the safety of this technology. We needed to analyze whether such dispersion of plasmid DNA might lead to unwanted expression of the transgene. As shown by real-time RT-PCR analysis in all organs, no such expression was determined at any time. These results give strong evidence that systemic distribution of plasmid DNA after intratumoral jet injection is not sufficient to generate gene transfer and transgene expression outside the actual jet-injected tumor tissue. One major explanation for this could be that the major compartment for the biodistribution of plasmid DNA is the rapidly circulating blood, by which DNA travels from the tumor to the various organs. It has been suggested, however, that such systemic DNA distribution occurs with insufficient time and proximity to the hypothesized DNA receptors on cells of these organs to permit endocytosis for efficient gene transfer (Liu and Huang, 2002) . This is supported by the finding that occlusion of the blood stream significantly improves gene transfer of naked DNA by increasing the retention time for the DNA applied (Liu and Huang, 2002) . Another explanation for the absence of gene expression in the various organs is that no physical energy forces the uptake of naked DNA into the cells of these organs.
In conclusion, our quantitative and qualitative analysis revealed that the topical application of naked plasmid DNA to tumors leads to efficient gene transfer and transgene expression. This expression was limited to the primary injection site, despite the fact that leakage of jet-injected DNA into other organs has been shown after intratumoral jet injection. In these organs, in particular, the rapid systemic clearance of plasmid DNA has been observed. These results support the notion that in vivo jet injection is a safe nonviral technology for gene therapy approaches.
